Digital Transformation in medicine: average is dead!
The life sciences sector – which includes the pharmaceutical and biotechnology sectors, the production of biomedical devices, and health services – is rapidly evolving. It is becoming increasingly clear that we are in a time of transition from “traditional” medicine to P4 medicine: predictive, preventive, personalized and participatory. One of the real drivers of this change is big data, which in precision medicine plays a fundamental role for health innovation.
The field of medicine is characterized by a significant accumulation of data from multiple sources: from genome sequencing to data generated from clinic research or the practice of health care. To these must be added data on nutrition, lifestyle, environment and general behaviour, even moods, which together produce an unprecedented reading of the interaction of our biological system with the environment that surrounds us. This allows a better definition of the transition from a state of health to one of disease, a crucial step in improving the effectiveness of health management for each one of us.
A better understanding of the data can become an opportunity for the health sector to increasingly focus on personalized solutions, consistent with the clinical profile and the lifestyle and consumption habits of the person emerging from all the available information.
Analysis of the data reveals a journey ahead full of challenges and problems on a wide scale, whose solution requires expertise about information technology/bioinformatics and artificial intelligence, storage capacity, interoperability of data from different sources, and regulations for their use, to protect people’s privacy and access to the research, and to avoid new monopolies capable of influencing the life of individuals and communities.
This year, the Scientific Committee of Meet in Italy for Life has decided to dedicate the closing international conference to the topic of the transformation of the health sector with an event entitled: “Digital transformation in medicine: average is dead!”, scheduled for 12 October from 9:30am at the Auditorium of Opificio Golinelli.
View and download the Keynote speaker presentation Alessandro Curioni (IBM Europe).
|9.30 am||Opening||Sergio Venturi, Councillor of health, Emilia Romagna Region|
|9.45 am||Keynote speaker||Alessandro Curioni, IBM Europe|
|10.45 am||Panel discussion
|Paolo Bandera, Bracco
Marco Dieci, Holostem TA
Francesca Fontana, ICT Legal Consulting
Claudio Giammatteo, Faschim
Enzo Grossi, ALISEI
Maria Luisa Lavitrano, University Milano Bicocca
Duccio Medini, GSK Vaccines
Maria Romano, Telbios
Alessandro Rotilio, R.A.W.
Elena Sgaravatti, Demetra Biotech
Andrea Urbani, Ministry of Health
|12.45 am||Closing of the works and presentation of the edition 2019||Diana Bracco, Presidente ALISEIReferente main organizer 2019|